The ovarian remnant syndrome and ureteral obstruction: Medical management

Michael Koch, D. Coussens, L. Burnett

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.

Original languageEnglish (US)
Pages (from-to)158-160
Number of pages3
JournalJournal of Urology
Volume152
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Ureteral Obstruction
Ovariectomy
Gonadotropin-Releasing Hormone
Recurrence
Therapeutics
Surveys and Questionnaires

Keywords

  • gonadorelin
  • ovariectomy

ASJC Scopus subject areas

  • Urology

Cite this

The ovarian remnant syndrome and ureteral obstruction : Medical management. / Koch, Michael; Coussens, D.; Burnett, L.

In: Journal of Urology, Vol. 152, No. 1, 1994, p. 158-160.

Research output: Contribution to journalArticle

Koch, M, Coussens, D & Burnett, L 1994, 'The ovarian remnant syndrome and ureteral obstruction: Medical management', Journal of Urology, vol. 152, no. 1, pp. 158-160.
Koch, Michael ; Coussens, D. ; Burnett, L. / The ovarian remnant syndrome and ureteral obstruction : Medical management. In: Journal of Urology. 1994 ; Vol. 152, No. 1. pp. 158-160.
@article{cb17ac75eabf44c5858c65ec81c92ead,
title = "The ovarian remnant syndrome and ureteral obstruction: Medical management",
abstract = "The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.",
keywords = "gonadorelin, ovariectomy",
author = "Michael Koch and D. Coussens and L. Burnett",
year = "1994",
language = "English (US)",
volume = "152",
pages = "158--160",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The ovarian remnant syndrome and ureteral obstruction

T2 - Medical management

AU - Koch, Michael

AU - Coussens, D.

AU - Burnett, L.

PY - 1994

Y1 - 1994

N2 - The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.

AB - The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.

KW - gonadorelin

KW - ovariectomy

UR - http://www.scopus.com/inward/record.url?scp=0028284311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028284311&partnerID=8YFLogxK

M3 - Article

C2 - 8201651

AN - SCOPUS:0028284311

VL - 152

SP - 158

EP - 160

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -